Dr. Jan Kriegl

After obtaining a PhD in Physics at the University of Ulm, in 2003 Jan Kriegl joined Boehringer Ingelheim as a PostDoc in Computational Chemistry, developing machine learning models for small molecule drug discovery. He then worked several years as scientist in Computer-Aided drug design in multiple research projects in several therapeutic areas before he became Head of Computational Chemistry. 

In 2017 Jan Kriegl joined Boehringer Ingelheim’s digital innovation lab BI X as a Product Owner. Since 2019 he is a member of the leadership team of Computational Innovation, part of Boehringer’s global organization for Research, pre-clinical and early clinical Development. He is overseeing teams that provide data for bioinformaticians in drug discovery projects and develop AI and machine learning applications for discovery and evaluation of novel drug targets and biomarkers. 

In addition, Jan Kriegl contributes to steering the R&D-specific IT and digital infrastructure at Boehringer Ingelheim.